QQQ   426.76 (+0.22%)
AAPL   167.96 (-0.02%)
MSFT   408.77 (-0.75%)
META   508.84 (+2.97%)
GOOGL   155.93 (+0.30%)
AMZN   181.54 (+0.14%)
TSLA   151.26 (-2.70%)
NVDA   852.25 (+1.42%)
AMD   155.70 (+1.09%)
NIO   4.03 (+3.07%)
BABA   69.31 (+0.71%)
T   16.15 (+0.19%)
F   12.10 (+0.50%)
MU   116.63 (+0.26%)
GE   157.77 (+1.35%)
CGC   7.04 (+8.47%)
DIS   113.63 (+0.61%)
AMC   2.83 (-5.03%)
PFE   25.39 (-0.12%)
PYPL   63.02 (-0.38%)
XOM   118.81 (+0.15%)
QQQ   426.76 (+0.22%)
AAPL   167.96 (-0.02%)
MSFT   408.77 (-0.75%)
META   508.84 (+2.97%)
GOOGL   155.93 (+0.30%)
AMZN   181.54 (+0.14%)
TSLA   151.26 (-2.70%)
NVDA   852.25 (+1.42%)
AMD   155.70 (+1.09%)
NIO   4.03 (+3.07%)
BABA   69.31 (+0.71%)
T   16.15 (+0.19%)
F   12.10 (+0.50%)
MU   116.63 (+0.26%)
GE   157.77 (+1.35%)
CGC   7.04 (+8.47%)
DIS   113.63 (+0.61%)
AMC   2.83 (-5.03%)
PFE   25.39 (-0.12%)
PYPL   63.02 (-0.38%)
XOM   118.81 (+0.15%)
QQQ   426.76 (+0.22%)
AAPL   167.96 (-0.02%)
MSFT   408.77 (-0.75%)
META   508.84 (+2.97%)
GOOGL   155.93 (+0.30%)
AMZN   181.54 (+0.14%)
TSLA   151.26 (-2.70%)
NVDA   852.25 (+1.42%)
AMD   155.70 (+1.09%)
NIO   4.03 (+3.07%)
BABA   69.31 (+0.71%)
T   16.15 (+0.19%)
F   12.10 (+0.50%)
MU   116.63 (+0.26%)
GE   157.77 (+1.35%)
CGC   7.04 (+8.47%)
DIS   113.63 (+0.61%)
AMC   2.83 (-5.03%)
PFE   25.39 (-0.12%)
PYPL   63.02 (-0.38%)
XOM   118.81 (+0.15%)
QQQ   426.76 (+0.22%)
AAPL   167.96 (-0.02%)
MSFT   408.77 (-0.75%)
META   508.84 (+2.97%)
GOOGL   155.93 (+0.30%)
AMZN   181.54 (+0.14%)
TSLA   151.26 (-2.70%)
NVDA   852.25 (+1.42%)
AMD   155.70 (+1.09%)
NIO   4.03 (+3.07%)
BABA   69.31 (+0.71%)
T   16.15 (+0.19%)
F   12.10 (+0.50%)
MU   116.63 (+0.26%)
GE   157.77 (+1.35%)
CGC   7.04 (+8.47%)
DIS   113.63 (+0.61%)
AMC   2.83 (-5.03%)
PFE   25.39 (-0.12%)
PYPL   63.02 (-0.38%)
XOM   118.81 (+0.15%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
$0.05
$0.07
$0.11
$5.00
$5.60M-1.922,942 shsN/A
Ener-Core, Inc. stock logo
ENCR
Ener-Core
$0.00
$0.00
$0.00
N/A22.14N/AN/A
GlyEco, Inc. stock logo
GLYE
GlyEco
$0.00
$0.00
$0.00
$0.00
N/AN/AN/AN/A
HighCom Global Security, Inc. stock logo
HCGS
HighCom Global Security
$0.00
$0.00
$0.00
N/AN/AN/AN/A
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
$0.07
$0.09
$0.06
$0.17
$7.83M0.0732,749 shs36,263 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
0.00%0.00%-38.35%-50.00%-75.25%
Ener-Core, Inc. stock logo
ENCR
Ener-Core
0.00%0.00%0.00%0.00%-50.00%
GlyEco, Inc. stock logo
GLYE
GlyEco
0.00%0.00%0.00%0.00%0.00%
HighCom Global Security, Inc. stock logo
HCGS
HighCom Global Security
0.00%0.00%0.00%0.00%-80.00%
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
+4.48%-11.84%-22.22%-46.15%-46.15%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Ener-Core, Inc. stock logo
ENCR
Ener-Core
N/AN/AN/AN/AN/AN/AN/AN/A
GlyEco, Inc. stock logo
GLYE
GlyEco
N/AN/AN/AN/AN/AN/AN/AN/A
HighCom Global Security, Inc. stock logo
HCGS
HighCom Global Security
N/AN/AN/AN/AN/AN/AN/AN/A
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
N/AN/AN/AN/A
Ener-Core, Inc. stock logo
ENCR
Ener-Core
N/AN/AN/AN/A
GlyEco, Inc. stock logo
GLYE
GlyEco
N/AN/AN/AN/A
HighCom Global Security, Inc. stock logo
HCGS
HighCom Global Security
N/AN/AN/AN/A
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
$310K18.07N/AN/A($0.01) per share-5.00
Ener-Core, Inc. stock logo
ENCR
Ener-Core
N/AN/AN/AN/AN/AN/A
GlyEco, Inc. stock logo
GLYE
GlyEco
N/AN/AN/AN/AN/AN/A
HighCom Global Security, Inc. stock logo
HCGS
HighCom Global Security
N/AN/AN/AN/AN/AN/A
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
$1.87M4.19N/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
-$1.36MN/A0.00N/A-299.54%N/A-425.51%N/A
Ener-Core, Inc. stock logo
ENCR
Ener-Core
N/AN/A0.00N/AN/AN/AN/AN/AN/A
GlyEco, Inc. stock logo
GLYE
GlyEco
N/AN/A0.00N/AN/AN/AN/AN/A
HighCom Global Security, Inc. stock logo
HCGS
HighCom Global Security
N/AN/A0.00N/AN/AN/AN/AN/AN/A
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
-$3.96M-$0.06N/AN/A-194.80%-717.03%-326.30%6/12/2024 (Estimated)

Latest PURE, HCGS, GLYE, ATMS, and ENCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/18/2024Q2 2024
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
N/A-$0.01-$0.01-$0.01N/A$0.33 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
N/AN/AN/AN/AN/A
Ener-Core, Inc. stock logo
ENCR
Ener-Core
N/AN/AN/AN/AN/A
GlyEco, Inc. stock logo
GLYE
GlyEco
N/AN/AN/AN/AN/A
HighCom Global Security, Inc. stock logo
HCGS
HighCom Global Security
N/AN/AN/AN/AN/A
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
N/A
0.15
0.12
Ener-Core, Inc. stock logo
ENCR
Ener-Core
N/AN/AN/A
GlyEco, Inc. stock logo
GLYE
GlyEco
N/AN/AN/A
HighCom Global Security, Inc. stock logo
HCGS
HighCom Global Security
N/AN/AN/A
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
3.75
1.72
1.59

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
N/A
Ener-Core, Inc. stock logo
ENCR
Ener-Core
N/A
GlyEco, Inc. stock logo
GLYE
GlyEco
N/A
HighCom Global Security, Inc. stock logo
HCGS
HighCom Global Security
N/A
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
N/A

Insider Ownership

CompanyInsider Ownership
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
7.45%
Ener-Core, Inc. stock logo
ENCR
Ener-Core
3.81%
GlyEco, Inc. stock logo
GLYE
GlyEco
22.09%
HighCom Global Security, Inc. stock logo
HCGS
HighCom Global Security
16.00%
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
41.76%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Artemis Therapeutics Inc. stock logo
ATMS
Artemis Therapeutics
1112.03 million103.69 millionNot Optionable
Ener-Core, Inc. stock logo
ENCR
Ener-Core
103.83 millionN/ANot Optionable
GlyEco, Inc. stock logo
GLYE
GlyEco
18N/AN/ANot Optionable
HighCom Global Security, Inc. stock logo
HCGS
HighCom Global Security
2,017N/AN/ANot Optionable
PURE Bioscience, Inc. stock logo
PURE
PURE Bioscience
11111.86 million65.15 millionNot Optionable

PURE, HCGS, GLYE, ATMS, and ENCR Headlines

SourceHeadline
PURE Bioscience, Inc. (PURE)PURE Bioscience, Inc. (PURE)
finance.yahoo.com - April 15 at 9:22 PM
Seragon Biosciencess RESTORIN Revolutionizes the Anti-Aging MarketSeragon Biosciences's RESTORIN Revolutionizes the Anti-Aging Market
ibtimes.com - April 15 at 4:22 PM
4JO: Burg Presents USAC Sprint Midwest Opener on Saturday4JO: Burg Presents USAC Sprint Midwest Opener on Saturday
speedwaydigest.com - April 13 at 8:30 PM
Pro-Palestine group at Harvard organizes student referendum on Israel divestmentPro-Palestine group at Harvard organizes student referendum on Israel divestment
forward.com - April 12 at 8:29 AM
Harvard Student Government Approves PSC Petition for Referendum on Israel DivestmentHarvard Student Government Approves PSC Petition for Referendum on Israel Divestment
thecrimson.com - April 11 at 10:20 AM
Top Iconic Brands to watch in 2024Top Iconic Brands to watch in 2024
timesofindia.indiatimes.com - April 1 at 12:36 PM
New school-wide dress code inspires unprecedented backlashNew school-wide dress code inspires unprecedented backlash
msuexponent.com - March 28 at 8:09 PM
UVA Law Professor Discusses Judicial Deference at Harvard Law School’s Annual Scalia LectureUVA Law Professor Discusses Judicial Deference at Harvard Law School’s Annual Scalia Lecture
thecrimson.com - March 28 at 1:25 PM
Scientists say theyre closer to reviving Mammoths. What could go wrong?Scientists say they're closer to reviving Mammoths. What could go wrong?
msn.com - March 28 at 1:25 PM
Sam Altmans mission to increase human lifespan with a $180 million shipping container experiment at Retro BiosciencesSam Altman's mission to increase human lifespan with a $180 million shipping container experiment at Retro Biosciences
msn.com - March 23 at 10:16 AM
PURE Bioscience Reports Fiscal Second Quarter 2024 Financial ResultsPURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results
businesswire.com - March 18 at 4:05 PM
Research: Red clover can act to deliver improved silage qualityResearch: Red clover can act to deliver improved silage quality
agriland.ie - March 16 at 10:49 PM
As European dynamism gathers momentum, Elaia and partners double down with new deep tech fundAs European dynamism gathers momentum, Elaia and partners double down with new deep tech fund
yahoo.com - March 14 at 1:57 AM
Sophie Bai Creates Scientific Breakthroughs for Her Skincare Brand, PaviseSophie Bai Creates Scientific Breakthroughs for Her Skincare Brand, Pavise
wmagazine.com - March 13 at 8:06 PM
Kuros Biosciences AG: Kuros Reports 163% Growth in Direct MagnetOs Sales and 153% Increase in Total Medical Device Sales for the Full Year 2023Kuros Biosciences AG: Kuros Reports 163% Growth in Direct MagnetOs Sales and 153% Increase in Total Medical Device Sales for the Full Year 2023
finanznachrichten.de - March 13 at 10:05 AM
Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
markets.businessinsider.com - March 13 at 10:05 AM
Resurrecting the mammoth: Elephant breakthrough gets us a step closerResurrecting the mammoth: Elephant breakthrough gets us a step closer
newatlas.com - March 13 at 10:05 AM
Imo Assembly Threatens Closure Of Pure Water FactoriesImo Assembly Threatens Closure Of Pure Water Factories
leadership.ng - March 12 at 1:50 PM
Global Catalase Market Set to Reach US$ 516.6 Million by 2032 with a 2.9% CAGR SurgeGlobal Catalase Market Set to Reach US$ 516.6 Million by 2032 with a 2.9% CAGR Surge
fmiblog.com - March 12 at 1:50 PM
Activists petition to remove methylene chloride from common decaf coffee production method amid carcinogen concernsActivists petition to remove methylene chloride from common decaf coffee production method amid carcinogen concerns
foodnavigator-usa.com - March 11 at 8:36 PM
How are peptide barcodes used for NGS?How are peptide barcodes used for NGS?
news-medical.net - March 11 at 3:35 PM
Climate dispatch from AfghanistanClimate dispatch from Afghanistan
theecologist.org - March 8 at 2:32 AM
Moligo Technologies Appoints John Kuijpers as Chief Business OfficerMoligo Technologies Appoints John Kuijpers as Chief Business Officer
finance.yahoo.com - March 7 at 9:44 AM
Vedanta Biosciences to Host Investor Meetings at the Leerink Partners 2024 Global Biopharma ConferenceVedanta Biosciences to Host Investor Meetings at the Leerink Partners 2024 Global Biopharma Conference
finance.yahoo.com - March 6 at 7:16 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Artemis Therapeutics logo

Artemis Therapeutics

OTCMKTS:ATMS
Artemis Therapeutics, Inc. is a biopharmaceutical company. It develops new treatments for serious and life-threatening infections. It Includes cytomegalovirus and malaria. The company was founded on April 22, 1997 and was headquartered in New York, NY.
Ener-Core logo

Ener-Core

OTCMKTS:ENCR
Ener-Core, Inc. designs, develops, manufactures, license, and market its products that are based on Power Oxidizer technologies. The company's Power Oxidizer technology generates industrial levels of usable heat in a pressure vessel using various organic gases as fuel for an oxidation reaction. Its products include Ener-Core PowerStation EC250 and Ener-Core Powerstation KG2-3GEF/PO, which have applications in landfills, distilleries, and various industrial processes. The company sells its products directly, as well as through distributors in the United States and the Netherlands. Ener-Core, Inc. was founded in 2008 and is headquartered in Irvine, California.
GlyEco logo

GlyEco

OTCMKTS:GLYE
GlyEco, Inc. engages in the development and manufacture of coolants, additives and related performance fluids. Its products and services include additives, ethylene glycol and antifreeze. The company was founded by Janet Carnell Lorenz, John Darc Lorenz, II and Todd L. Smith on April 21, 1997 and is headquartered in Rock Hill, SC.
HighCom Global Security logo

HighCom Global Security

OTCMKTS:HCGS
HighCom Global Security, Inc., together with its subsidiaries, designs, develops, manufactures, and distributes security products and personal protective gears in the United States and internationally. The company offers ballistic helmets, hard armor plates, soft armor vests, and ballistic shields. It also provides BlastWrap, a blast mitigation technology that contains explosions and suppresses resulting flash fires. The company was formerly known as BlastGard International, Inc. and changed its name to HighCom Global Security, Inc. in June 2017. HighCom Global Security, Inc. was incorporated in 2003 and is based in Columbus, Ohio.
PURE Bioscience logo

PURE Bioscience

OTCMKTS:PURE
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.